These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 1983864

  • 1. Late effects of allogeneic bone marrow transplantation in children.
    Bender-Götze C.
    Pediatrician; 1991; 18(1):71-5. PubMed ID: 1983864
    [Abstract] [Full Text] [Related]

  • 2. [Cataract in children after autologous bone marrow transplantation. A common, but curable complication].
    Frisk P, Hagberg H, Mandahl A, Söderberg P, Lönnerholm G.
    Lakartidningen; 2002 Mar 27; 99(13):1444-7. PubMed ID: 11989353
    [Abstract] [Full Text] [Related]

  • 3. Late effects in children after bone marrow transplantation: a review.
    Locatelli F, Giorgiani G, Pession A, Bozzola M.
    Haematologica; 1993 Mar 27; 78(5):319-28. PubMed ID: 8314162
    [Abstract] [Full Text] [Related]

  • 4. Long-term renal function following bone marrow transplantation.
    Grönroos MH, Bolme P, Winiarski J, Berg UB.
    Bone Marrow Transplant; 2007 Jun 27; 39(11):717-23. PubMed ID: 17401393
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M, Esperou Bourdeau H, Devergie A, Baruchel A, Ribaud P, Socie G, Parquet N, Traineau R, Hirsch I, Schaison G.
    Bone Marrow Transplant; 1995 Jun 27; 15(6):943-7. PubMed ID: 7581095
    [Abstract] [Full Text] [Related]

  • 6. Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre.
    Bruno B, Souillet G, Bertrand Y, Werck-Gallois MC, So Satta A, Bellon G.
    Bone Marrow Transplant; 2004 Jul 27; 34(2):143-7. PubMed ID: 15170172
    [Abstract] [Full Text] [Related]

  • 7. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD, Amylon MD, Stockerl-Goldstein KE, Negrin RS, Chao NJ, Hu WW, Nademanee AP, Snyder DS, Hoppe RT, Vora N, Wong R, Niland J, Reichardt VL, Forman SJ, Blume KG.
    Biol Blood Marrow Transplant; 1997 Dec 27; 3(6):324-30. PubMed ID: 9502300
    [Abstract] [Full Text] [Related]

  • 8. Allogeneic bone marrow transplantation in the treatment of hematologic diseases.
    Yee GC, McGuire TR.
    Clin Pharm; 1985 Dec 27; 4(2):149-60. PubMed ID: 3886273
    [Abstract] [Full Text] [Related]

  • 9. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hematologic diseases.
    Tauchmanovà L, Selleri C, Rosa GD, Pagano L, Orio F, Lombardi G, Rotoli B, Colao A.
    Cancer; 2002 Sep 01; 95(5):1076-84. PubMed ID: 12209694
    [Abstract] [Full Text] [Related]

  • 10. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S.
    Bone Marrow Transplant; 1996 Oct 01; 18(4):741-6. PubMed ID: 8899189
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation: acute and late complications.
    Tabbara IA.
    Anticancer Res; 1996 Oct 01; 16(2):1019-26. PubMed ID: 8687093
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Late effects after allogeneic bone marrow transplantation.
    Dicke KA.
    Bone Marrow Transplant; 1994 Oct 01; 14 Suppl 4():S11-3. PubMed ID: 7728118
    [No Abstract] [Full Text] [Related]

  • 15. Renal involvement in bone marrow transplantation.
    Otani M, Shimojo H, Shiozawa S, Shigematsu H.
    Nephrology (Carlton); 2005 Oct 01; 10(5):530-6. PubMed ID: 16221108
    [Abstract] [Full Text] [Related]

  • 16. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V, Castagnola E, Dallorso S, Lanino E, Calvi A, Silvestro S, Morreale G, Giacchino R, Dini G.
    Bone Marrow Transplant; 1999 Feb 01; 23(3):271-5. PubMed ID: 10084259
    [Abstract] [Full Text] [Related]

  • 17. Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.
    Yoshida Y, Hirano T, Son G, Iimuro Y, Imado T, Iwasaki T, Fujimoto J.
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec 01; 293(6):G1114-23. PubMed ID: 17761834
    [Abstract] [Full Text] [Related]

  • 18. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D, DeFor T, Burns L, McGlave P, Miller J, Wagner J, Weisdorf D.
    Biol Blood Marrow Transplant; 2003 Jan 01; 9(1):52-9. PubMed ID: 12533742
    [Abstract] [Full Text] [Related]

  • 19. Growth in children following irradiation for bone marrow transplantation.
    Bushhouse S, Ramsay NK, Pescovitz OH, Kim T, Robison LL.
    Am J Pediatr Hematol Oncol; 1989 Jan 01; 11(2):134-40. PubMed ID: 2665547
    [Abstract] [Full Text] [Related]

  • 20. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen.
    Hale GA, Bowman LC, Woodard JP, Cunningham JM, Benaim E, Horwitz EM, Heslop HE, Krance RA, Leung W, Shearer PD, Handgretinger R.
    Bone Marrow Transplant; 2003 Jun 01; 31(11):981-6. PubMed ID: 12774048
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.